Quantitation of Bone Mass in Osteoporosis: Recent Advances

  • C. H. ChesnutIII
  • W. B. Nelp
  • T. K. Lewellen

Abstract

Knowledge of the pathophysiology and treatment of osteoporosis and other metabolic bone disease is enhanced by accurate measurement of bone mineral mass and precise estimation of bone mass change. Ideally, a non-invasive measurement of bone mass in the osteoporotic patient would precisely quantitate both regional bone mass at selected sites and total skeletal bone mass, since it may be that some skeletal sites change more rapidly than others when bone loss or gain occurs; consequently, regional measurements of one site may not reflect the state of other sites or of the entire skeleton.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aloia, J.F., Ellis, K., Zanzi, I. & Cohn, S.H.: Photon absorptiometry and skeletal mass in the treatment of osteoporosis. J. NucL Med. 17, 196–199 (1975)Google Scholar
  2. 2.
    Chesnut, C.H. III, Nelp, W.B., Denney, J.D. & Sherrard, D.J.: Measurement of total body calcium (bone mass) by neutron activation analysis: Applicability to bone-wasting disease. Clin. Aspects of Metabolic Bone Disease, Excerpta Medica (Amst.), pp. 50–54, 1972Google Scholar
  3. 3.
    Chesnut, C.H. III, Nelp, W.B. & Baylink, D.: Efficacy of Dianabol in osteoporosis as determined by changes in total bone mineral mass (Abstract): Clin. Res. 22, 464a (1974)Google Scholar
  4. 4.
    Cohn, S.H., Ellis, K.J., Wallach, S., Zanzi, I. et al.: Absolute and relative deficit in total skeletal calcium and radial bone mass in osteoporosis. J. Nucl. Med. 15, 428–435 (1974)Google Scholar
  5. 5.
    Dudl, R.J., Ensinck, J.W., Baylink, D., Chesnut, C.H. III et al.: Evaluation of intravenous calcium as therapy for osteoporosis. Amer. J. Med. 55, 631–637 (1973)CrossRefGoogle Scholar
  6. 6.
    Lewellen, T.K., Chesnut, C.H. III, Nelp, W.B., Palmer, H.E. et al.: Preliminary observations on the excretion of argon-37 from man following whole body neutron activation — an indicator of total body calcium. J. Nucl. Med. 16, 672–675 (1975)PubMedGoogle Scholar
  7. 7.
    Manzke, E., Chesnut, C.H. III, Wergedal, J.E., Baylink, D.J. et al.: Relationship between local and total bone mass in osteoporosis. Metabolism 25, 605–615 (1975)CrossRefGoogle Scholar
  8. 8.
    Nelp, W.B., Palmer, H.E., Murano, R., Pailthorp, K. et al.: Measurement of total body caldium (bone mass) in vivo with the use of total body neutrom activation analysis. J. Lab, clin. Med. 76, 151–162 (1970)Google Scholar
  9. 9.
    Nelp, W.B., Denney, J.D., Murano, R., Hinn, G.M. et al.: Absolute measurement of total body calcium (bone mass) in vivo. J. Lab, clin. Med. 79, 430–437 (1972)Google Scholar
  10. 10.
    Wheden, G.D., Lutwak, L., Rambaut, P.C., Whittle, M.W. et al.: Mineral and nitrogen metabolic studies. Proceedings of the Skylab Life Sciences Symposium Vol. 1, NASA Technical Memorandum (eds.), pp. 353–371, 1974Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1976

Authors and Affiliations

  • C. H. ChesnutIII
    • 1
  • W. B. Nelp
    • 1
  • T. K. Lewellen
    • 1
  1. 1.Division of Nuclear MedicineUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations